Tags: Drug.
The combination preparation fluticasone/salmeterol is a formulation containing fluticasone propionate and salmeterol xinafoate used in the management of asthma and chronic obstructive pulmonary disease (COPD). It is marketed by GlaxoSmithKline under various trade names including Advair (in the US and Canada) Seretide (Brazil India Australia Colombia EU México New Zealand South Africa South Korea UK Estonia) Viani (Germany) Adoair (Japan) and Foxair (South Africa).
